Search

Search results

Potential drug targets identified for RP

A recently published study has described numerous disease mechanisms that appear to be common across different types of inherited sight loss, suggesting that there is significant potential for drug treatments that could work regardless of the underlying causative gene.

Eppendorf tubes in rack

Research round-up, spring 2023

Progress towards treatments for inherited retinal conditions continues to gather pace and there’s been lots going on in the last few months, with more and more approaches being explored. This round-up gives a flavour of the variety of developments, including plenty that are not specific to a particular genetic fault.

The cover of Look Forward Summer 2024 (issue 183) featuring a group of eight people looking down at the camera with blue sky above them

Look Forward – Summer 2024 – Issue 183

This edition includes exciting news about our Annual and Professionals’ Conferences. We hope as many of you as possible can join us in Manchester, or online, in September. You’ll also find updates about the latest research and a feature on one of our funded researchers, Dr Jörn Lakowski.

Does gene therapy always have to be gene-specific?

Early 2020 marked an important milestone for the Retina UK community, when the first person with an inherited retinal condition received NHS treatment to potentially slow or even stop the progression of their sight loss.

x-linked inheritance

X-linked inheritance means that the faulty gene is located on the X chromosome, the larger of the two sex chromosomes.